Can you do better than the experts in treating immunoglobulin A nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS)? Using a case-based vignette, chairperson Siân Griffin, MD, PhD, and faculty members Jürgen Floege, MD, and Loreto Gesualdo, MD, will provide expert analysis regarding the value of lowering proteinuria and offer insights on applying clinical trial data to the unique challenges of managing advanced nephropathy. Learn how novel mechanisms, innovative treatments, and emerging data are leading to successful outcomes in patients with IgAN and FSGS.
To view the full symposium on Achieving Success in IgAN & FSGS: Expert Insights on Current and Future Therapies, click here.
Facebook Comments